Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Coherus Biosciences' Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study 8/15/2014 6:34:54 AM
FDA Advisory Committee Recommends Approval Of Tiotropium Respimat® For The Maintenance Treatment Of COPD 8/15/2014 8:24:12 AM
Sanofi Pasteur (SASY.PA) Touts Positive Trial Data For Fluzone High-Dose Vaccine 8/14/2014 6:26:10 AM
Pfizer Inc. (PFE) Reports Top-Line Results From Two Placebo-Controlled Studies With Lyrica 8/13/2014 6:09:35 AM
Scientists Retract Narcolepsy Study Linked To GlaxoSmithKline (GSK) Flu Vaccine 8/7/2014 2:57:13 PM
Ampio Pharmaceuticals, Inc. (AMPE) Updates On Positive One-Month Results From Ampion Open Label Study 8/5/2014 6:56:25 AM
Berlin Heart, Inc. Completes Enrollment In The EXCOR® Pediatric Ventricular Assist Device (VAD) Post Approval Study 8/4/2014 11:02:31 AM
Hemispherx Biopharma (HEB)'s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses 8/4/2014 8:24:03 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: European Commission Grants Orphan Drug Designation To Soliris® (Eculizumab) For The Treatment Of Patients With Myasthenia Gravis (MG) 8/1/2014 10:21:58 AM
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding 7/24/2014 6:34:56 AM
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 7/21/2014 10:47:02 AM
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study 7/18/2014 6:56:54 AM
Bristol-Myers Squibb Company (BMY) And Pfizer Inc. (PFE) Announce Enrollment Of First Patient In Phase IV EMANATE Trial To Assess Effectiveness And Safety Of Eliquis® (Apixaban) In Patients With NVAF Undergoing Cardioversion 7/17/2014 9:42:56 AM
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Candidiasis 7/16/2014 10:35:01 AM
ACell, Inc. Initiates Post-Market Study Of MatriStem® Pelvic Floor Matrix 7/15/2014 9:30:19 AM
1234567
//-->